Mendell Helium PLC has secured a further £12,000 in funding through the issue of 400,000 new ordinary shares at 3p each, as it continues to progress its strategy in the US helium sector.
Investors in the placing also received warrants exercisable at 4.5p and 6p, providing additional potential upside if the company’s growth plans gather pace.
In a related move, Mendell has extended the exercise period for AlbR Capital Limited’s broker option to acquire up to 10 million shares, pushing the deadline back to December 3, 2025. The newly issued shares are expected to be admitted to trading on December 1, 2025, at which point total voting rights will rise to 123,237,973.
The fundraising comes as the company continues to pursue its option to acquire M3 Helium, a helium producer based in Kansas. The deadline to exercise this option has also been extended, now running until November 30, 2025, giving Mendell additional time to progress negotiations and due diligence.
The update signals ongoing momentum in Mendell’s strategy to build a foothold in the strategically important helium market, although the modest size of the raise underlines its early-stage position.
Engage with the Mendell Helium management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here: https://mendellhelium.com/s/a6a55a
Enquiries:
|
Investor questions on this announcement We encourage all investors to share questions on this announcement via our investor website
|
|
|
Mendell Helium plc Nick Tulloch, CEO
|
Via our website |
